IP Library Granted Patent US 7,896,920
Granted Patent B2
US 7,896,920 · App. 11/932,066 · Granted Mar 1, 2011

In situ bioprosthetic filler and method, particularly for the in situ formation of vertebral disc bioprosthetics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,896,920
App. No.
11/932,066
Granted
Mar 1, 2011
Kind
B2
Abstract

Bioprosthetic devices include an exterior biological tissue member which at least partly defines a cavity, and a proteinaceous biopolymer which fills the cavity, and intercalates and is chemically bound (fixed) to the tissue of the surrounding biological tissue member. In preferred forms, the bioprosthetic device is a bioprosthetic vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity and is formed by removal of at least a substantial portion of the natural gelatinous core therefrom. The cavity defined by the fibrillar outer annulus may then be filled with a flowable proteinaceous biopolymer. Preferably, the proteinaceous biopolymer is a liquid mixture comprised of human or animal-derived protein material and a di- or polyaldehyde, which are allowed to react in situ to form a cross-linked biopolymer within the cavity. The liquid mixture may be formed in advance of being introduced into the cavity, or may be formed simultaneously during introduction into the cavity.

Claims (34)

1. A method for the in situ formation of a bioprosthetic core for a vertebral disc comprising:

substantially filling a cavity of the vertebral disc defined by a surrounding biological tissue material with a flowable material which comprises:

a first reactable component consisting of a human or animal derived protein material and a second reactable component consisting of a di- or polyaldehyde material, and/or

reaction products of the first reactable component and the second reactable component; and

allowing the first reactable component and second reactable component or their reaction products to at least partly solidify within the biological tissue material and chemically bind to the surrounding biological tissue material, thereby forming the bioprosthetic core, the bioprosthetic core being load distributing and compressible without exhibiting substantial permanent deformation.

2. The method of claim 1 , which comprises injecting the flowable material into the cavity.

3. The method of claim 2 , wherein the first reactable component and the second reactable component are combined and mixed simultaneously while being injected into the cavity.

4. The method of claim 2 , wherein the first reactable component and the second reactable component are premixed before being injected into the cavity.

5. The method of claim 1 , further comprising providing a fibrous or particulate filler material in the flowable material.

6. The method of claim 1 , wherein the protein material comprises bovine or human serum albumin or hemoglobin.

7. The method of claim 1 , wherein the di- or polyaldehyde comprises glutaraldehyde.

8. The method of claim 1 , wherein the di- or polyaldehyde is present in a weight ratio of one part by weight to every 20-60 parts of protein present by weight prior to reacting with the first reactable component.

9. A method for the formation of a bioprosthetic core for a vertebral disc comprising:

(a) providing a vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity formed by removal of a natural gelatinous core material therefrom;

(b) substantially filling the cavity with a flowable material which comprises a first reactable component consisting of a human or animal derived protein material and a second reactable component consisting of a di- or polyaldehyde material, and/or reaction products of the first reactable component and the second reactable component; and

(c) reacting the first and second reactable components so that the flowable material at least partly solidifies in situ within the cavity and chemically binds to the surrounding biological tissue of the cavity thereby forming the bioprosthetic core, the vertebral disc having the bioprosthetic core therein exhibiting flexibility comparable to a biologically natural vertebral disc.

10. The method of claim 9 , which comprises injecting the first and second reactable components in situ within the cavity, and allowing the first and second reactable components to at least partly solidify by reaction therein.

11. The method of claim 10 , wherein the first reactable component and the second reactable component are combined and mixed simultaneously while being injected into the cavity.

12. The method of claim 10 , wherein the first reactable component and the second reactable component are premixed before being injected into the cavity.

13. The method of claim 9 , further comprising providing a fibrous or particulate filler material in the flowable material.

14. The method of claim 9 , wherein the protein material comprises bovine or human serum albumin or hemoglobin.

15. The method of claim 9 , wherein the di- or polyaldehyde comprises glutaraldehyde.

16. The method of claim 9 , wherein the di- or polyaldehyde is present in a weight ratio of one part by weight to every 20-60 parts of protein present by weight prior to reacting with the first reactable component.

17. A method for the formation of a bioprosthetic core for a vertebral disc comprising:

(a) providing a vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity formed by removal of a natural gelatinous core material therefrom;

(b) substantially filling the cavity with a flowable material which comprises a first reactable component consisting of a human or animal derived protein material and a second reactable component consisting of a di- or polyaldehyde material, and/or reaction products of the first reactable component and the second reactable component; and

(c) reacting the first and second reactable components so that the flowable material at least partly solidifies in situ within the cavity and chemically binds to the surrounding biological tissue of the cavity thereby forming the bioprosthetic core, the bioprosthetic core being capable of withstanding compression for 100 and 1000 cycles at a compression rate of 100 mm/min between a minimum stress of 200 kPa and a maximum stress of 800 kPa without exhibiting permanent deformation and loss of hydration.

18. The method of claim 17 , which comprises injecting the first and second reactable components in situ within the cavity, and allowing the first and second reactable components to at least partly solidify by reaction therein.

19. The method of claim 18 , wherein the first reactable component and the second reactable component are combined and mixed simultaneously while being injected into the cavity.

20. The method of claim 18 , wherein the first reactable component and the second reactable component are premixed before being injected into the cavity.

21. The method of claim 17 , further comprising providing a fibrous or particulate filler material in the flowable material.

22. The method of claim 17 , wherein the protein material comprises bovine or human serum albumin or hemoglobin.

23. The method of claim 17 , wherein the di- or polyaldehyde comprises glutaraldehyde.

24. The method of claim 17 , wherein the di- or polyaldehyde is present in a weight ratio of one part by weight to every 20-60 parts of protein present by weight prior to reacting with the first reactable component.

Assignments (6)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2024
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC.
Reel/Frame 066360/0562 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2017
From: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044616/0940 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →
SECURITY AGREEMENT Recorded Oct 31, 2011
From: CRYOLIFE, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 027146/0940 →